Schivo Expands MedTech Capabilities with Mecaplast Acquisition

Schivo announced the acquisition of Mecaplast, a Swiss manufacturer specializing in high-precision plastics, metals, and ceramics injection molding for the medical device and life sciences sectors. The move expands Schivo’s expertise in advanced materials and strengthens its position as a global partner for complex MedTech and life sciences technologies.

The integration adds plastic, metal, and ceramic manufacturing, assembly, and value-added services to Schivo’s vertical platform. Schivo will also establish a European Center of Excellence, enhancing injection molding capacities in plastics and metals. These capabilities will support operations in the United States and Mexico, strengthening services for MedTech and life sciences OEMs across key international markets.

“Mecaplast brings decades of deep expertise in complex plastics, metals, and ceramics, aligning with our vision of creating a global, multi-capability platform for advanced medical devices and life sciences,” says Graham Reeves, CEO, Schivo. “Their focus on innovation further strengthens our ability to deliver fully integrated solutions across materials, technologies, and markets.”

Mecaplast’s facilities will serve as Schivo’s Global Center of Excellence for molding precision plastics, metals, and ceramics. The acquisition highlights Schivo’s strategy to expand its capabilities and international reach while reinforcing its role in the development and commercialization of next-generation medical and life sciences technologies.